Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Apr 27, 2021 11:12pm
149 Views
Post# 33080266

RE:RE:RE:And now for something completely different

RE:RE:RE:And now for something completely differentRead this again. They don't propose new legislation to crack down on online disinformation scams like what you're witnessing here over nothing. It's a very real, very widespread, and present threat.
Jonnyboy85 wrote:
Jonnyboy85 wrote: "the OSC would not need to prove that the market was distorted by the statement or statements (i.e., there would be no causation requirement).An intention to impact the market or influence a reasonable investors decision-making would be sufficient."
Jonnyboy85 wrote: If you're into the regulatory changes going on right now that will affect shorting and a lot of other unlawful activities like what you're seeing on this board I've attached the link for the report by the Ontario Capital Markets Modernization Taskforce. it's dry but theres a lot of good info there. #25 and #26 on shorting is good and #57 applies directly to stockhouse and public spaces such as these. quoted below


https://files.ontario.ca/books/mof-capital-markets-modernization-taskforce-final-report-en-2021-01-22-v2.pdf


57.Create a prohibition to effectively deter and prosecute misleading or untrue statements about public companies and attempts to make such statements


There have been cases where a series of unsubstantiated statements are made publicly for financial gain, and misleading or false information is introduced into the market to intentionally or recklessly affect the share price of public companies and influence the investment decisions of investors. Such schemes are sometimes referred to as “short and distort” campaigns (where there is profit from falling share prices) or as “pump and dump” schemes (where there is profit from increasing or inflated share prices).


The advent of technology in recent years, including for example the use of social media, has changed the nature and tactics of these schemes. In addition to accessing a much wider audience, campaigns can be sustained with many misleading or false statements made over a prolonged period. British Columbia recently enacted legislation that will help combat such abusive schemes. Many commenters indicated support for this recommendation.


Recommendation:


The Taskforce recommends creating a new and specific prohibition on making misleading or untrue statements about public companies. This will make it easier for the OSC to effectively deter and combat abusive practices intended to affect share prices or influence investor decisions, such as “short and distort” campaigns and “pump and dump” schemes. The prohibition would also cover attempts to make “misleading or untrue statements about public companies” to address the abusive practices that may not be successful, but which are still egregious.


The prohibition would allow the OSC to take enforcement action targeting any person or entity who makes one or more statements about a public company, where those statements are known to be (or there is a reckless disregard for whether these statements are) misleading or untrue, and when those statements, taken on their own or together, would be expected to either affect the market price or value of the securities of the public company or derivatives based on such securities, or influence the investment decision-making of a reasonable investor in respect of these securities or derivatives.


To enforce the prohibition, the OSC would not need to prove that the market was distorted by the statement or statements (i.e., there would be no causation requirement). An intention to impact the market or influence a reasonable investor’s decision-making would be sufficient. This prohibition is not meant to capture analysts who frequently provide their researched views on reporting issuers’ securities, and who may omit facts without the intent to mislead. It is also not meant to stifle the legitimate dissemination of public information by analysts or reputable activist short sellers. Indeed, the Taskforce acknowledges that reputable activist short sellers’ public comments can be important for price correction of a public issuer’s securities.






<< Previous
Bullboard Posts
Next >>